Therapeutic efficacy and safety of initial triple combination of metformin sitagliptin and lobeglitazone in drug-naïve patients with type 2 diabetes: initial triple study

摘要

To compare the efficacy and safety of an initial triple therapy using metformin, a dipeptidyl peptidase-4 (DPP4) inhibitor, and thiazolidinedione with a stepwise approach using sulfonylurea and metformin in new-onset, drug-naïve patients with type 2 diabetes.